Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/14/2025

Management of Gastrointestinal Symptoms

Initial Clinical Assessment

  • The American Gastroenterological Association recommends focusing on specific alarm features that mandate immediate investigation, such as weight loss >10% which suggests malabsorption, malignancy, or serious underlying disease requiring urgent workup 3
  • Gastrointestinal bleeding (visible blood or melena) requires urgent evaluation, as it may indicate a serious underlying condition 3
  • Iron-deficiency anemia warrants celiac disease testing and possible endoscopy, as it may be a sign of malabsorption or underlying disease 3
  • Persistent or severe vomiting may indicate gastroparesis or obstruction, and requires further evaluation 3
  • A family history of inflammatory bowel disease or colorectal cancer increases the risk of these conditions, and should be considered in the initial assessment 3

Diagnostic Testing Strategy

  • The American College of Gastroenterology recommends reserving abdominal imaging and upper endoscopy exclusively for patients with alarm features, recent worsening symptoms, or abnormal physical examination findings 1, 2
  • Tissue transglutaminase IgA with total IgA levels should be tested for celiac disease screening, particularly if diarrhea or weight loss is present 3, 2
  • A complete blood count and comprehensive metabolic panel should only be performed when alarm symptoms are present or systemic disease is suspected 3, 2
  • Thyroid function and glucose testing should be performed to screen for hypothyroidism and diabetes, which can affect GI motility 5

First-Line Treatment: Dietary Modifications

  • The American Gastroenterological Association recommends implementing dietary modifications for 3-4 weeks before considering other interventions 2
  • Small evening meals with longer intervals between eating and lying down may help mitigate symptoms of nausea, vomiting, and abdominal pain from delayed gastric emptying 6
  • A low-FODMAP diet may be effective for suspected carbohydrate intolerance, as lactose intolerance affects 51% and fructose intolerance affects 60% of patients with bloating 4
  • Gluten and fructan restriction may be beneficial for patients with self-reported gluten sensitivity, as fructans rather than gluten may cause symptoms 3, 4

Pharmacological Management

  • Prokinetic agents, such as metoclopramide 10-20 mg every 6-8 hours, are first-line therapy for gastroparesis-related symptoms 6
  • Secretagogues (linaclotide, lubiprostone) may be effective for abdominal bloating when constipation is present 3, 2
  • Rifaximin may be effective for small intestinal bacterial overgrowth (SIBO)-related bloating, particularly in high-risk patients with chronic watery diarrhea, malnutrition, or systemic diseases causing dysmotility 3, 4

Brain-Gut Behavioral Therapies

  • Psychological therapies, such as hypnotherapy and cognitive behavioral therapy, may be used to treat patients with bloating and distention, as up to one-third of people with IBS also experience anxiety or depression 1, 2
  • Diaphragmatic breathing and central neuromodulators may be used to treat abdominophrenic dyssynergia, which involves inappropriate diaphragm contraction causing abdominal distention typically worse after meals 1, 7, 4

Critical Pitfalls to Avoid

  • Over-testing in functional bloating, as the absence of alarm symptoms makes extensive imaging, endoscopy, and motility testing unnecessary and low-yield 3
  • Assuming gastroparesis based on symptoms alone, as bloating, nausea, and fullness do not correlate with the degree of gastric emptying delay on scintigraphy 3
  • Ignoring pelvic floor dysfunction, as straining with soft stool or need for manual assistance suggests dyssynergia, not just constipation 3
  • Using probiotics to treat abdominal bloating and distention, as they are not recommended for this purpose 1, 2